Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • tirohia
    Member
    • Nov 2011
    • 47

    #1

    collapsing multiple genes into a meta-gene.

    The end goal is to cluster some time series data.

    Using multiple different methods, I've identified a number of differentially expressed genes over a timecourse.
    I've got two possible sets of genes I can work with. ~2,000 out of ~70,000 genes have been identified as differentially expressed by at 3 out of the 5 methods I'm using. Or alternatively ~200 have been identified by all 5 methods.

    The 3000 gene set is to big to cluster - BHC can deal with time series data (I can use it on the smaller dataset), but on a data set that size it locks up the machine overnight and then crashes.
    How does one go about reducing the dimensionality of the set? As in, I'd like to collapse groups of genes with similar expression profiles within that 2,000 to be represented by a single metagene. Or are there better methods of clustering time series data?

    The bioconductor package Farm, appears to do this, but only for data presented in affybatch form, which I don't have - mines all RNASeq data in an expressionSet.

    Cheers
    Ben.
  • sphil
    Senior Member
    • Apr 2010
    • 192

    #2
    If I understand correctly you want to reduce your dimensionality without loosing information (as far as possible). What comes into my mind is that you need some kind of pre clustering using some sort of algorithm without having much apriori information. So, I'd recommend looking into it using DBSCAN as a clustering algorithm...
    It really needs minimal settings to work reasonably well and can cluster similar genes over the course into one cluster. After that you can work with one representative of those cluster in your downstream analysis. Another thing would be SOMs (self-organizing maps). Haven't done a lot with those, tbh.

    HTH

    Phil

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:35 AM
    0 responses
    7 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...